Online citations, reference lists, and bibliographies.
← Back to Search

Apolipoprotein E Alleles As Risk Factors In Alzheimer's Disease.

A. Roses
Published 1996 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Alzheimer's disease (AD) is unique in medicine in that millions of people suffer from what appears to be the same form of disease, and unlike most other late-onset diseases, the genetic etiologies have been well identified. Three early onset forms of AD inherited as autosomal dominant traits account for less than 2% of prevalent AD. A major susceptibility locus, apolipoprotein E (APOE, gene; apoE, protein) is associated with risk and age of onset distributions for the common familial and sporadic late-onset AD. The identification of additional genetic susceptibility genes in the etiology of AD and the metabolic mechanisms leading to differences in age of onset and disease pathogenesis are active areas of current research.
This paper references
10.1212/WNL.13.10.811
Familial Alzheimer's disease
R. Feldman (1963)
10.1212/WNL.34.7.939
Clinical diagnosis of Alzheimer's disease
G. Mckhann (1984)
10.1001/ARCHNEUR.1985.04060100083029
Diagnosis of Alzheimer's disease.
Z. Khachaturian (1985)
The affected-pedigree-member method of linkage analysis.
D. Weeks (1988)
The affectedpedigreemember method of linkage analy
DE Weeks (1988)
10.1038/349704A0
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
A. Goate (1991)
10.1212/WNL.41.4.479
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
S. Mirra (1991)
Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.
M. Pericak-Vance (1991)
10.1016/0006-8993(91)91092-F
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
Y. Namba (1991)
10.1016/0140-6736(92)92890-R
Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography
A. D. Smith (1992)
10.1016/0168-0102(92)90014-4
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases
H. Braak (1992)
10.1016/0140-6736(93)92404-H
Apolipoprotein E-∈A allele and Alzheimer's disease
N. Anwar (1993)
10.1016/0304-3940(93)90373-S
A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer's disease
A. Ueki (1993)
10.1016/0140-6736(93)91705-Q
Apolipoprotein E polymorphism and Alzheimer's disease
J. Poirier (1993)
10.1016/0140-6736(93)91458-X
Linkage of late-onset Alzheimer's disease with apolipoprotein E type 4 on chromosome 19
D. Borgaonkar (1993)
10.1016/0140-6736(93)91728-5
Apolipoprotein E genotype and Alzheimer's disease
S. Noguchi (1993)
10.1073/PNAS.90.5.1977
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
W. Strittmatter (1993)
10.1016/0896-6273(93)90070-8
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
G. Rebeck (1993)
CONFIRMATION THAT THE APOLIPOPROTEIN E4 ALLELE IS ASSOCIATED WITH LATE-ONSET, FAMILIAL ALZHEIMERS-DISEASE
H. Houlden (1993)
10.1002/ANA.410340527
The apolipoprotein ε4 allele in patients with Alzheimer's disease
R. Mayeux (1993)
10.1073/PNAS.90.20.9649
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease.
D. Schmechel (1993)
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
P. Amouyel (1993)
10.1016/0140-6736(93)92405-I
Movement of the rhabditiform larva of Strongyloides stercoralis
João Nicanildo Bastos dos Santos (1993)
10.1126/SCIENCE.8346443
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
E. Corder (1993)
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease.
A. Saunders (1993)
10.1016/0140-6736(93)91709-U
Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases
A. Saunders (1993)
Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
G. Lucotte (1993)
10.1073/PNAS.90.17.8098
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.
W. Strittmatter (1993)
The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease.Ann
R Mayeux (1993)
10.1097/00005072-199409000-00013
Apolipoprotein E Is Localized to the Cytoplasm of Human Cortical Neurons: A Light and Electron Microscopic Study
Seol-Heul Han (1994)
10.1006/exnr.1994.1108
Apolipoprotein E Is Present in Hippocampal Neurons without Neurofibrillary Tangles in Alzheimer's Disease and in Age-Matched Controls
Seol-Heui Han (1994)
10.1126/SCIENCE.8290965
Alzheimer's disease and possible gene interaction.
P. St George-Hyslop (1994)
10.11501/3115006
Association of apolipoprotein E with sporadic Alzheimer's disease
戴 小燕 (1994)
10.1073/PNAS.91.23.11183
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.
W. Strittmatter (1994)
10.1212/WNL.44.12.2420
Apolipoprotein E ε4
S. Sakoda (1994)
10.1038/NG0694-180
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
E. Corder (1994)
10.1136/bmj.309.6955.636
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study
J. Kuusisto (1994)
10.1016/0304-3940(94)90204-6
Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease
David Y. Huang (1994)
10.1002/AJMG.1320540319
Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.
G. Lucotte (1994)
10.1006/exnr.1994.1019
Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype
W. Strittmatter (1994)
10.1016/0304-3940(94)90384-0
Lack of association between apolipoprotein E allele ɛ4 and sporadic Alzheimer's disease
L. Lannfelt (1994)
10.1038/NG0194-29
Genetic associations with human longevity at the APOE and ACE loci
F. Schächter (1994)
Genetic dissection of complex traits science
E. Lander (1994)
10.1038/NG0594-10B
ApoE–ε4 and early–onset Alzheimer's
K. Okuizumi (1994)
10.1016/S0140-6736(94)92960-2
Clinical application of apolipoprotein E genotyping to Alzheimer's disease
A. Roses (1994)
10.1016/S0065-3233(08)60642-7
Apolipoprotein E: structure-function relationships.
K. Weisgraber (1994)
Lack of association between apolipoprotein E allele epsilon 4 and sporadic Alzheimer's disease.
L. Lannfelt (1994)
10.1097/00005072-199409000-00002
Apolipoprotein E Affects the Rate of Alzheimer Disease Expression: (β-Amyloid Burden Is a Secondary Consequence Dependent on APOE Genotype and Duration of Disease
A. Roses (1994)
10.1212/WNL.44.12.2420-A
Apolipoprotein E epsilon 4.
S. Sakoda (1994)
10.1136/jnnp.57.11.1414
Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia.
J. Kawamata (1994)
10.1016/S0140-6736(94)92028-1
Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease
K. Jobst (1994)
10.1038/NG0594-74
Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease
C. Duijn (1994)
ApoE-epsilon4 and early-onset Alzheimer’s (letter).Nat
K Okuizumi (1994)
10.1001/JAMA.1995.03520400044042
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.
R. Petersen (1995)
10.1038/NM0295-135
Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury
J. Nicoll (1995)
10.1038/375754A0
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
R. Sherrington (1995)
10.1038/NM0795-603
Head injury, amyloid β and Alzheimer's disease
A. Roses (1995)
10.1016/S0140-6736(95)91411-0
ApoE genotype and survival from intracerebral haemorrhage
M. Alberts (1995)
10.1016/0304-3940(94)11100-W
ApoE genotype and familial Alzheimer's disease: a possible influence on age of onset in APP717 Val → Ile mutated families
B. Nacmias (1995)
10.1126/science.7638622
Candidate gene for the chromosome 1 familial Alzheimer's disease locus
E. Levy-Lahad (1995)
10.1016/0003-4975(95)00076-W
Predictors of cognitive decline after cardiac operation.
M. Newman (1995)
10.1001/JAMA.1995.03520360056039
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease.
G. Small (1995)
10.1016/0304-3940(94)11107-T
Apolipoprotein ϵ4 allele and disease progression in patients with late-onset Alzheimer's disease
H. Basun (1995)
10.1126/science.7638621
A familial Alzheimer's disease locus on chromosome 1
E. Levy-Lahad (1995)
10.1212/WNL.45.7.1323
Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease
E. Corder (1995)
Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease.
H. Basun (1995)
10.1002/ANA.410370123
Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans
H. Hendrie (1995)
10.1056/NEJM199511093331902
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
T. Polvikoski (1995)
10.1002/ANA.410380105
Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease
A. Roses (1995)
10.1016/0306-4522(94)00596-W
Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation
T. Ohm (1995)
10.1002/ANA.410370217
Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks
G. Maestre (1995)
Apolipoprotein E, dementia, and cortical deposition ofβ-amyloid protein.N
T Polvikoski (1995)
Characterization of the apolipoprotein E genotypes in clinical trials of Alzheimer’s disease: the S12024 (memory enhancer) European multicentre project
P Anouyel (1995)
ApolipoproteinE status as a predictor of the development of Alzheimer ’ s disease in memoryimpaired individuals
AD Smith (1995)
A familial Alzheimer’s disease locus on chromosome
E Levy-Lahad (1995)
10.1212/WNL.46.1.142
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIII.
G. Fillenbaum (1996)
10.1038/NG0496-355
Genetic dissection of complex traits
J. Witte (1996)
10.1007/978-3-642-80109-9_3
Apolipoprotein E4, Cholinergic Integrity, Synaptic Plasticity and Alzheimer’s Disease
J. Poirier (1996)



This paper is referenced by
10.1080/09603123.2021.1973969
PM2.5 exposure and olfactory functions.
John Andersson (2021)
10.3233/ADR-210014
Clustering Alzheimer’s Disease Gene Expression Dataset Reveals Underlying Sexually Dimorphic and Disease Status Profiles
S. Levy (2021)
10.1007/s12274-021-3865-2
Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
Tianzhong Li (2021)
10.1101/2021.10.07.21264646
Leveraging large multi-center cohorts of Alzheimer Disease endophenotypes to understand the role of Klotho heterozygosity on disease risk
M. Ali (2021)
10.1101/2021.09.09.21263324
Exploration of Alzheimer's Disease MRI Biomarkers Using APOE4 Carrier Status in the UK Biobank
J. Du (2021)
10.1002/anbr.202100097
Advances in Modeling Alzheimer's Disease In Vitro
Navatha Shree Sharma (2021)
10.1016/j.nbd.2021.105558
Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models
(2021)
10.1016/j.arr.2020.101212
β-amyloid: The known unknowns
S. Ayton (2020)
10.1186/s13073-021-00959-y
A transcriptome-wide association study of Alzheimer’s disease using prediction models of relevant tissues identifies novel candidate susceptibility genes
Yanfa Sun (2021)
10.1126/scitranslmed.aaz4564
APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia
Grzegorz Sienski (2021)
10.1016/j.neuroimage.2021.118586
MRI-based Alzheimer’s disease prediction via distilling the knowledge in multi-modal data
Hao Guan (2021)
10.1007/s11011-021-00673-z
Metabolic disorder in Alzheimer's disease.
M. Poddar (2021)
10.1111/jnc.15465
Mass spectrometry‐based methods for robust measurement of Alzheimer's disease biomarkers in biological fluids
M. Korecka (2021)
10.1038/s41583-021-00533-w
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.
(2021)
10.3233/JAD-210492
Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer’s Disease Mice
Yassin Watson (2021)
10.3390/ijms21041289
Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology
Amit Koren-Iton (2020)
10.1101/2020.03.26.010330
Cell type-specific histone acetylation profiling of Alzheimer’s Disease subjects and integration with genetics
Easwaran Ramamurthy (2020)
10.1242/dmm.045211
Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
Julia Gamache (2020)
10.1016/b978-0-12-815854-8.00009-4
Genetics of dementia
F. Fernandez (2020)
10.3233/JAD-190983
"Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.
Hyun-Ju Yang (2020)
10.1186/s13024-020-0358-9
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Tosha Williams (2020)
10.3389/fneur.2020.00614
A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
S. Manzano (2020)
10.3233/JAD-200439
Risk Factors Predicting Amyloid PET Positivity in Patients with Mild Cognitive Impairment and Apolipoprotein E ɛ3/ɛ3 Genotypes.
Seong Hee Ho (2020)
10.1002/trc2.12117
APOE ε4/ε4 homozygotes with early Alzheimer's disease show accelerated hippocampal atrophy and cortical thinning that correlates with cognitive decline
S. Abushakra (2020)
10.1016/j.addr.2020.04.013
Lipid efflux mechanisms, relation to disease and potential therapeutic aspects.
David Castaño (2020)
10.1111/bpa.12842
Investigation of pathology, expression and proteomic profiles in human TREM2 variant postmortem brains with and without Alzheimer’s disease
Christina E. Toomey (2020)
10.1007/s40588-020-00146-4
Perspectives on the Intracellular Bacterium Chlamydia pneumoniae in Late-Onset Dementia
B. Balin (2020)
10.3233/JAD-200321
Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer’s Disease and Their Epistatic Interaction
S. Šutovský (2020)
The interactive impact of omega-3 fatty acids, APOE genotype and sex hormones on cognition
Matthew G. Pontifex (2020)
10.1186/s13195-020-00585-7
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
K. Minta (2020)
10.1038/s41582-020-0362-2
Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities
K. Davis (2020)
10.3390/ijms21239153
The Role of Mitochondrial Calcium Homeostasis in Alzheimer’s and Related Diseases
Kerry C Ryan (2020)
See more
Semantic Scholar Logo Some data provided by SemanticScholar